ZEPTOMETRIX LLC

ZEPTOMETRIX LLC specializes in the design and development of specialized serological reagent panels for biomedical research applications, with a focus on precision diagnostics and immune response characterization. Their core capability centers on the engineering of high-specificity antigen arrays and control matrices used to detect antibody seroconversion events in clinical and preclinical studies. The company leverages advanced immunoassay platforms and molecular binding kinetics to deliver standardized, reproducible panels that support vaccine efficacy tracking, infectious disease surveillance, and immunological profiling. Their technical expertise includes antigen selection, epitope mapping, and assay validation under controlled laboratory conditions, with an emphasis on reproducibility and analytical sensitivity in low-abundance target detection. The contractor has demonstrated direct engagement with the Department of Health and Human Services, delivering research-grade diagnostic tools aligned with public health surveillance objectives. Their work supports HHS-funded initiatives focused on infectious disease response, likely contributing to studies involving pathogen immunity, vaccine development, or epidemiological modeling. ZEPTOMETRIX operates within the research and development domain defined by NAICS 541715, concentrating on physical and life science applications that bridge laboratory innovation and real-world diagnostic utility. They position themselves as a niche provider of custom serological tooling for government-funded biomedical research, distinct from broad biotech or pharmaceutical contractors by focusing on assay development rather than therapeutic production. As a small entity structured as a 2K firm, ZEPTOMETRIX maintains a lean operational footprint based in Vernon Hills, Illinois. While currently holding no formal government certifications, their work reflects a disciplined approach to quality control and scientific validation consistent with federal research standards. Their market presence is defined by targeted, high-impact contributions to specialized public health research programs.